Jessica Ritsick, Yifan Wang, Ph.D. Our FDA: Drug & Device Team analyzes the Food and Drug Administration’s new guidance on Bayesian approaches to innovative drug trials, providing greater clarity on ...
This is a guest post by Nathan Paxton. As social scientists, at least as regards what we can empirically assess, we tend to make statements of probability rather than fact. So rather than say that ...
The Simon two-stage minimax design is a popular statistical design used in Phase II clinical trials. The analysis of the data arising from the design typically involves the use of frequentist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results